Vicplas International (SGX:569) ROCE % : 1.47% (As of Jan. 2024)

View and export this data going back to 1999. Start your Free Trial

What is Vicplas International ROCE %?

ROCE % measures how well a company generates profits from its capital. It is calculated as EBIT divided by Capital Employed, where Capital Employed is calculated as Total Assets minus Total Current Liabilities. Vicplas International's annualized ROCE % for the quarter that ended in Jan. 2024 was 1.47%.

Vicplas International ROCE % Historical Data

The historical data trend for Vicplas International's ROCE % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Vicplas International ROCE % Chart

Vicplas International Annual Data

Trend

Jul14

Jul15

Jul16

Jul17

Jul18

Jul19

Jul20

Jul21

Jul22

Jul23

ROCE %

Get a 7-Day Free Trial

7.04

11.96

16.45

12.98

7.25

Vicplas International Semi-Annual Data
	Jul14	Jan15	Jul15	Jan16	Jul16	Jan17	Jul17	Jan18	Jul18	Jan19	Jul19	Jan20	Jul20	Jan21	Jul21	Jan22	Jul22	Jan23	Jul23	Jan24
ROCE %	Get a 7-Day Free Trial															13.95	11.86	8.25	6.28	1.47

Vicplas International ROCE % Calculation

Vicplas International's annualized ROCE % for the fiscal year that ended in Jul. 2023 is calculated as:

ROCE %	=	EBIT	/	( (Capital Employed	+	Capital Employed)	/ count )
		(A: Jul. 2023 )		(A: Jul. 2022 )		(A: Jul. 2023 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(A: Jul. 2023 )		(A: Jul. 2022 )		(A: Jul. 2023 )
	=	6.767	/	( ( (130.343 - 35.511)	+	(119.021 - 27.251) )	/ 2 )
	=	6.767	/	( (94.832	+	91.77)	/ 2 )
	=	6.767	/	93.301
	=	7.25 %

Vicplas International's ROCE % of for the quarter that ended in Jan. 2024 is calculated as:

ROCE %	=	EBIT ⁽¹⁾	/	( (Capital Employed	+	Capital Employed)	/ count )
		(Q: Jan. 2024 )		(Q: Jul. 2023 )		(Q: Jan. 2024 )
	=	EBIT	/	( ( (Total Assets - Total Current Liabilities)	+	(Total Assets - Total Current Liabilities) )	/ count )
		(Q: Jan. 2024 )		(Q: Jul. 2023 )		(Q: Jan. 2024 )
	=	1.378	/	( ( (119.021 - 27.251)	+	(126.646 - 31.245) )	/ 2 )
	=	1.378	/	( ( 91.77	+	95.401 )	/ 2 )
	=	1.378	/	93.5855
	=	1.47 %

(1) Note: The EBIT data used here is two times the semi-annual (Jan. 2024) EBIT data.

Vicplas International (SGX:569) ROCE % Explanation

ROCE % can be especially useful when comparing the performance of capital-intensive companies. Unlike ROE %, which indicates the profitability of Shareholders Equity, ROCE % also considers long-term debt in Capital Employed. This can be helpful when analyzing companies with significant debt, as the result is neutralized by taking debt into consideration.

Generally speaking, a higher ROCE % indicates a stonger profitability for a company. Moreover, it is important to look at the ratio from a long term perspective. Investors tend to favor companies with stable and rising ROCE % trend over those with volatile ones.

Vicplas International ROCE % Related Terms

Thank you for viewing the detailed overview of Vicplas International's ROCE % provided by GuruFocus.com. Please click on the following links to see related term pages.

Vicplas International (SGX:569) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Vicplas International Ltd (SGX:569) » Definitions » ROCE %

Comparable Companies

Traded in Other Exchanges

N/A

Address

35 Joo Koon Circle, Singapore, SGP, 629110

Website

https://www.vicplas.com

Vicplas International Ltd is an investment holding company. The company is organized into two main business activities: the Pipes and Pipe Fitting segment and the Medical Devices segment, which is the key revenue driver. Pipes and Pipe Fittings segment engages in the manufacturing and distribution of plastic building products, including uPVC pipes and pipe fittings and electrical conduits. The Medical device segment is involved in the research, design, development, and manufacture of medical devices. The company generates majority of its revenue from medical devices. The company does its sales through geographical segments that include Singapore, Malaysia, China, and the United Kingdom, of which the majority of the revenue comes from Singapore.

Vicplas International (SGX:569) Headlines

No Headlines